• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Soaring Eagle Acquisition Corp. (Amendment)

    10/1/21 5:02:37 PM ET
    $SRNG
    Get the next $SRNG alert in real time by email
    SC 13D/A 1 efc21-533_sc13da.htm
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549



    SCHEDULE 13D
    Under the Securities Exchange Act of 1934
    (Amendment No. 1)*

    Ginkgo Bioworks Holdings, Inc.
    (Name of Issuer)

    Class A Common Stock, par value $0.0001 per share
    (Title of Class of Securities)

    37611X100
    (CUSIP Number)

    Andrew Genser
    General Counsel
    55 Railroad Avenue
    Greenwich, Connecticut 06830
    203-863-7050
    (Name, Address and Telephone Number of Person
    Authorized to Receive Notices and Communications)

    September 27, 2021
    (Date of Event which Requires Filing of this Statement)

    If the filing persons has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐
    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
     

     
    SCHEDULE 13D
     
     
     
     
    CUSIP No.: 37611X100
     
    Page 2 of 12 Pages

    1
    NAMES OF REPORTING PERSONS
       
    VIKING GLOBAL INVESTORS LP
       
       
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a)
    ☐
     
    (b)
    ☐
       
    3
    SEC USE ONLY
       
         
       
    4
    SOURCE OF FUNDS (SEE INSTRUCTIONS)
       
    AF
       
       
    5
    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
     
    ☐
         
       
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
    Delaware
       
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    7
    SOLE VOTING POWER
       
    0
       
       
    8
    SHARED VOTING POWER
       
    302,942,974 (1)
       
       
    9
    SOLE DISPOSITIVE POWER
       
    0
       
       
    10
    SHARED DISPOSITIVE POWER
       
    302,942,974 (1)
       
       
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
    302,942,974 (1)
       
       
    12
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
         
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
       
    22.8% (2)
       
       
    14
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
       
    PN
       
       
     
    1.
    See Item 5 of the Schedule 13D.
     
    2.
    The percentages set forth herein are based on 1,330,072,374 shares of Common Stock outstanding upon closing of the Issuer’s Business Combination on September 16, 2021, according to the Issuer’s prospectus supplement on Form 424B3 dated September 20, 2021.


     
    SCHEDULE 13D
     
     
     
     
    CUSIP No.: 37611X100
     
    Page 3 of 12 Pages
    1
    NAMES OF REPORTING PERSONS
       
    VIKING GLOBAL OPPORTUNITIES PARENT GP LLC
       
       
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a)
    ☐
     
    (b)
    ☐
       
    3
    SEC USE ONLY
       
         
       
    4
    SOURCE OF FUNDS (SEE INSTRUCTIONS)
       
    AF
       
       
    5
    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
     
    ☐
         
       
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
    Delaware
       
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    7
    SOLE VOTING POWER
       
    0
       
       
    8
    SHARED VOTING POWER
       
    302,942,974 (1)
       
       
    9
    SOLE DISPOSITIVE POWER
       
    0
       
       
    10
    SHARED DISPOSITIVE POWER
       
    302,942,974 (1)
       
       
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
    302,942,974 (1)
       
       
    12
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
         
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
       
    22.8% (2)
       
       
    14
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
       
    OO
       
       
     
    1.
    See Item 5 of the Schedule 13D.
     
    2.
    The percentages set forth herein are based on 1,330,072,374 shares of Common Stock outstanding upon closing of the Issuer’s Business Combination on September 16, 2021, according to the Issuer’s prospectus supplement on Form 424B3 dated September 20, 2021.

     
    SCHEDULE 13D
     
     
     
     
    CUSIP No.: 37611X100
     
    Page 4 of 12 Pages
    1
    NAMES OF REPORTING PERSONS
       
    VIKING GLOBAL OPPORTUNITIES GP LLC
       
       
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a)
    ☐
     
    (b)
    ☐
       
    3
    SEC USE ONLY
       
         
       
    4
    SOURCE OF FUNDS (SEE INSTRUCTIONS)
       
    AF
       
       
    5
    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
     
    ☐
         
       
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
    Delaware
       
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    7
    SOLE VOTING POWER
       
    0
       
       
    8
    SHARED VOTING POWER
       
    302,942,974 (1)
       
       
    9
    SOLE DISPOSITIVE POWER
       
    0
       
       
    10
    SHARED DISPOSITIVE POWER
       
    302,942,974 (1)
       
       
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
    302,942,974 (1)
       
       
    12
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
         
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
       
    22.8% (2)
       
       
    14
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
       
    OO
       
       
     
    1.
    See Item 5 of the Schedule 13D.
     
    2.
    The percentages set forth herein are based on 1,330,072,374 shares of Common Stock outstanding upon closing of the Issuer’s Business Combination on September 16, 2021, according to the Issuer’s prospectus supplement on Form 424B3 dated September 20, 2021.

     
    SCHEDULE 13D
     
     
     
     
    CUSIP No.: 37611X100
     
    Page 5 of 12 Pages
    1
    NAMES OF REPORTING PERSONS
       
    VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC
       
       
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a)
    ☐
     
    (b)
    ☐
       
    3
    SEC USE ONLY
       
         
       
    4
    SOURCE OF FUNDS (SEE INSTRUCTIONS)
       
    AF
       
       
    5
    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
     
    ☐
         
       
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
    Delaware
       
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    7
    SOLE VOTING POWER
       
    0
       
       
    8
    SHARED VOTING POWER
       
    302,942,974 (1)
       
       
    9
    SOLE DISPOSITIVE POWER
       
    0
       
       
    10
    SHARED DISPOSITIVE POWER
       
    302,942,974 (1)
       
       
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
    302,942,974 (1)
       
       
    12
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
         
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
       
    22.8% (2)
       
       
    14
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
       
    OO
       
       
     
    1.
    See Item 5 of the Schedule 13D.
     
    2.
    The percentages set forth herein are based on 1,330,072,374 shares of Common Stock outstanding upon closing of the Issuer’s Business Combination on September 16, 2021, according to the Issuer’s prospectus supplement on Form 424B3 dated September 20, 2021.

     
    SCHEDULE 13D
     
     
     
     
    CUSIP No.: 37611X100
     
    Page 6 of 12 Pages
    1
    NAMES OF REPORTING PERSONS
       
    VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP
       
       
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a)
    ☐
     
    (b)
    ☐
       
    3
    SEC USE ONLY
       
         
       
    4
    SOURCE OF FUNDS (SEE INSTRUCTIONS)
       
    WC
       
       
    5
    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
     
    ☐
         
       
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
    Cayman Islands
       
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    7
    SOLE VOTING POWER
       
    0
       
       
    8
    SHARED VOTING POWER
       
    302,942,974 (1)
       
       
    9
    SOLE DISPOSITIVE POWER
       
    0
       
       
    10
    SHARED DISPOSITIVE POWER
       
    302,942,974 (1)
       
       
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
    302,942,974 (1)
       
       
    12
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
         
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
       
    22.8% (2)
       
       
    14
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
       
    PN
       
       
     
    1.
    See Item 5 of the Schedule 13D.
     
    2.
    The percentages set forth herein are based on 1,330,072,374 shares of Common Stock outstanding upon closing of the Issuer’s Business Combination on September 16, 2021, according to the Issuer’s prospectus supplement on Form 424B3 dated September 20, 2021.

     
    SCHEDULE 13D
     
     
     
     
    CUSIP No.: 37611X100
     
    Page 7 of 12 Pages
    1
    NAMES OF REPORTING PERSONS
       
    O. ANDREAS HALVORSEN
       
       
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a)
    ☐
         
    3
    SEC USE ONLY
       
         
       
    4
    SOURCE OF FUNDS (SEE INSTRUCTIONS)
       
    AF
       
       
    5
    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
     
    ☐
         
       
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
    Norway
       
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    7
    SOLE VOTING POWER
       
    0
       
       
    8
    SHARED VOTING POWER
       
    302,942,974 (1)
       
       
    9
    SOLE DISPOSITIVE POWER
       
    0
       
       
    10
    SHARED DISPOSITIVE POWER
       
    302,942,974 (1)
       
       
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
    302,942,974 (1)
       
       
    12
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
         
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
       
    22.8% (2)
       
       
    14
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
       
    IN
       
       
     
    1.
    See Item 5 of the Schedule 13D.
     
    2.
    The percentages set forth herein are based on 1,330,072,374 shares of Common Stock outstanding upon closing of the Issuer’s Business Combination on September 16, 2021, according to the Issuer’s prospectus supplement on Form 424B3 dated September 20, 2021.

     
    SCHEDULE 13D
     
     
     
     
    CUSIP No.: 37611X100
     
    Page 8 of 12 Pages
    1
    NAMES OF REPORTING PERSONS
       
    DAVID C. OTT
       
       
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a)
    ☐
         
    3
    SEC USE ONLY
       
         
       
    4
    SOURCE OF FUNDS (SEE INSTRUCTIONS)
       
    AF
       
       
    5
    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
     
    ☐
         
       
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
    United States of America
       
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    7
    SOLE VOTING POWER
       
    0
       
       
    8
    SHARED VOTING POWER
       
    302,942,974 (1)
       
       
    9
    SOLE DISPOSITIVE POWER
       
    0
       
       
    10
    SHARED DISPOSITIVE POWER
       
    302,942,974 (1)
       
       
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
    302,942,974 (1)
       
       
    12
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
         
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
       
    22.8% (2)
       
       
    14
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
       
    IN
       
       
     
    1.
    See Item 5 of the Schedule 13D.
     
    2.
    The percentages set forth herein are based on 1,330,072,374 shares of Common Stock outstanding upon closing of the Issuer’s Business Combination on September 16, 2021, according to the Issuer’s prospectus supplement on Form 424B3 dated September 20, 2021.
     

     
    SCHEDULE 13D
     
     
     
     
    CUSIP No.: 37611X100
     
    Page 9 of 12 Pages
    1
    NAMES OF REPORTING PERSONS
       
    ROSE S. SHABET
       
       
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a)
    ☐
         
    3
    SEC USE ONLY
       
         
       
    4
    SOURCE OF FUNDS (SEE INSTRUCTIONS)
       
    AF
       
       
    5
    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
     
    ☐
         
       
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
    United States of America
       
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    7
    SOLE VOTING POWER
       
    0
       
       
    8
    SHARED VOTING POWER
       
    302,942,974 (1)
       
       
    9
    SOLE DISPOSITIVE POWER
       
    0
       
       
    10
    SHARED DISPOSITIVE POWER
       
    302,942,974 (1)
       
       
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
    302,942,974 (1)
       
       
    12
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
         
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
       
    22.8% (2)
       
       
    14
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
       
    IN
       
       
     
    1.
    See Item 5 of the Schedule 13D.
     
    2.
    The percentages set forth herein are based on 1,330,072,374 shares of Common Stock outstanding upon closing of the Issuer’s Business Combination on September 16, 2021, according to the Issuer’s prospectus supplement on Form 424B3 dated September 20, 2021.
     

     
    SCHEDULE 13D
     
     
     
     
    CUSIP No.: 37611X100
     
    Page 10 of 12 Pages
    EXPLANATORY NOTE

    Pursuant to Rule 13d-2 of the Securities Exchange Act of 1934, as amended, this Amendment No. 1 to the Schedule 13D amends certain items of the Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) on September 27, 2021 (the “Schedule 13D”) relating to the Class A Common Stock (the “Common Stock”), par value $0.0001 per share, of Ginkgo Bioworks Holdings, Inc., a corporation incorporated in Delaware, United States (the “Issuer” or “Company”). All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D.

    Item 2.
    Identity and Background

    Item 2 of the Schedule 13D is hereby amended and restated in its entirety as follows:

    (a-c, f) This Schedule 13D is filed jointly by each of the following persons (collectively, the “Reporting Persons”):


    i.
    Viking Global Investors LP (“VGI”),  a Delaware limited partnership;

    ii.
    Viking Global Opportunities Parent GP LLC (“Parent”), a Delaware limited liability company;

    iii.
    Viking Global Opportunities GP LLC (“Opportunities GP”), a Delaware limited liability company;

    iv.
    Viking Global Opportunities Portfolio GP LLC (“Opportunities Portfolio GP”), a Delaware limited liability company;

    v.
    Viking Global Opportunities Illiquid Investments Sub-Master LP (“VGOP”), a Cayman Islands exempted limited partnership;

    vi.
    O. Andreas Halvorsen (“Mr. Halvorsen”), a citizen of Norway;

    vii.
    David C. Ott (“Mr. Ott”), a citizen of the United States of America; and

    viii.
    Rose S. Shabet (Ms. Shabet), a citizen of the United States of America.

    The principal business address of each Reporting Person is 55 Railroad Avenue, Greenwich, Connecticut 06830.

    This Schedule 13D relates to the Common Stock (as defined herein) held directly by VGOP, an investment fund whose principal business is to engage in making investments in securities of public and private companies. The principal business of VGI is to provide managerial services to related entities engaged in making or recommending investments in securities of public and private companies. The principal business of each of Parent, Opportunities GP and Opportunities Portfolio GP is to serve as the sole member, general partner or investment manager of related entities engaged in making or recommending investments in securities of public and private companies. The present principal occupation of O. Andreas Halvorsen is Chief Executive Officer of VGI. The present principal occupation of David C. Ott is Advisory Director of VGI. The present principal occupation of Rose S. Shabet is Chief Operating Officer of VGI.

    The agreement among each of the Reporting Persons to file this Schedule 13D jointly in accordance with Rule 13d-1(k) of the Exchange Act is attached hereto as Exhibit 1.

    (d), (e) During the last five years, none of the Reporting Persons have (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

    Item 4.
    Purpose of Transaction

     Item 4 of the Schedule 13D is hereby amended and supplemented as follows:

    VGOP entered into a Stockholders Agreement with the Company on September 27, 2021, as amended and restated on October 1, 2021, pursuant to which, subject to the approval of the Company’s board of directors (the “Board”), VGOP agreed to surrender to the Company 285,000,000 shares of Common Stock directly held by VGOP (and beneficially owned by the Reporting Persons) and the Company agreed to accept such surrender of shares and issue an equal number of shares of Class C Common Stock to VGOP in exchange therefor (the “Exchange”).  The Company agreed to recommend the approval of the Exchange to the Board, and cause the Board to vote on the Exchange, no later than November 15, 2021.  The Class C Common Stock is convertible into Common Stock, on a one-for-one basis and at the holder’s option, upon at least sixty-one (61) days’ prior written notice to the Company.  Accordingly, if the Exchange is approved by the Board, the Reporting Persons will no longer be deemed to beneficially own the 285,000,000 shares of Common Stock subject to the Exchange.

    Item 6.
    Contracts, Arrangements, Undertakings or Relationships with Respect to Securities of the Issuer

    Item 6 of the Schedule 13D is hereby amended and supplemented as follows:

    The response to Item 4 of this Amendment No. 1 is incorporated by reference herein.

    Except as otherwise set forth in the Schedule 13D, as amended by Amendment No. 1, there are no contracts, arrangements, understandings or relationships between the Reporting Persons named in Item 2 and any other person with respect to any securities of the Issuer.

    Item 7.
    Material to Be Filed as Exhibits

    Item 7 of the Schedule 13D is hereby amended and supplemented as follows:

    Exhibit 4 – Joint Filing Agreement

     
    SCHEDULE 13D
     
     
     
     
    CUSIP No.: 37611X100
     
    Page 11 of 12 Pages

     
    SIGNATURE
     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


     
    By:
    /s/ Scott M. Hendler
     
     
    Name:
    Scott M. Hendler on behalf of O. Andreas Halvorsen (1)
       
     
    By:
    /s/ Scott M. Hendler
     
     
    Name:
    Scott M. Hendler on behalf of David C. Ott (2)
       
     
    By:
    /s/ Scott M. Hendler
     
     
    Name:
    Scott M. Hendler on behalf of Rose S. Shabet (3)
     
     
    (1) Scott M. Hendler is signing on behalf of O. Andreas Halvorsen, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, and VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Mr. Halvorsen on February 12, 2021 (SEC File No. 005-49737).
     
    (2) Scott M. Hendler is signing on behalf of David C. Ott, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, and VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Mr. Ott on February 12, 2021 (SEC File No. 005-49737).
     
    (3) Scott M. Hendler is signing on behalf of Rose S. Shabet, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, and VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Ms. Shabet on February 12, 2021 (SEC File No. 005-49737).
     
     


    October 1, 2021

    Attention: Intentional misstatements or omissions of act constitute federal violations (see 18 U.S.C. 1001).


     
    SCHEDULE 13D
     
     
     
     
    CUSIP No.: 37611X100
     
    Page 12 of 12 Pages

     
    EXHIBIT A - JOINT FILING AGREEMENT
     
    This joint filing agreement is made and entered into as of this 1st day of October, 2021, by and among Viking Global Investors LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet.
     
    The parties to this Agreement hereby agree to prepare jointly and file timely (and otherwise to deliver as appropriate) all filings on any Forms 3, 4, or 5 or Schedules 13D or 13G, and any and all amendments thereto and any other documents relating thereto (collectively, the “Filings”) as required to be filed pursuant to the Securities Exchange Act of 1934, as amended. The parties to this Agreement further agree and covenant that each will fully cooperate with such other parties in the preparation, timely filing, and delivery of all such Filings.
     
    IN WITNESS WHEREOF, the parties hereto have executed this agreement as of the date first set forth above.
     
    Dated:  October 1, 2021

     
         
     
    By:
    /s/ Scott M. Hendler
     
     
    Name:
    Scott M. Hendler on behalf of O. Andreas Halvorsen (1)
       
     
    By:
    /s/ Scott M. Hendler
     
     
    Name:
    Scott M. Hendler on behalf of David C. Ott (2)
       
     
    By:
    /s/ Scott M. Hendler
     
     
    Name:
    Scott M. Hendler on behalf of Rose S. Shabet (3)
     
    (1) Scott M. Hendler is signing on behalf of O. Andreas Halvorsen, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, and VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Mr. Halvorsen on February 12, 2021 (SEC File No. 005-49737).
     
    (2) Scott M. Hendler is signing on behalf of David C. Ott, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, and VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Mr. Ott on February 12, 2021 (SEC File No. 005-49737).
     
    (3) Scott M. Hendler is signing on behalf of Rose S. Shabet, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, and VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Ms. Shabet on February 12, 2021 (SEC File No. 005-49737).




    Get the next $SRNG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SRNG

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SRNG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ginkgo Bioworks to Go Public with Over $1.6 Billion in Proceeds

    Soaring Eagle Shareholder Approval Obtained, Closing Scheduled for September 16, 2021 Ginkgo Set to Begin Trading under NYSE: DNA on September 17, 2021 $1.633 billion in proceeds from the business combination represents the largest-ever biotechnology go-public transaction. Investors were led by Baillie Gifford, Putnam Investments, and funds and accounts managed by Counterpoint Global (Morgan Stanley Investment Management). Additional investors included ARK Investment Management LLC, ArrowMark Partners, Bain Capital Public Equity, Cascade Investment, Casdin Capital, Franklin Advisers, T. Rowe Price, and Viking Global Investors. Business combination with Ginkgo approved by Soaring Eagl

    9/14/21 9:13:00 AM ET
    $SRNG

    Africa CDC and Ginkgo Bioworks Announce Collaboration to Strengthen Laboratory Network Capacity Across African Union Member States

    BOSTON and ADDIS ABABA, Ethiopia, Sept. 14, 2021 /PRNewswire/ -- The Africa Centres for Disease Control and Prevention (Africa CDC), a specialized technical institution of the African Union, and Ginkgo Bioworks, which is building the leading horizontal platform for cell programming, today announced a partnership to bolster the laboratory network capacity for African Union Member States. The partnership is aimed at supporting the continent's public health institutions with appropriate tools, training, and data infrastructure to leverage critical genomic sequencing technologies that will be implemented through Africa CDC Institute for Pathogen Genomics (IPG) and Ginkgo Bioworks.  Gin

    9/14/21 7:58:00 AM ET
    $SRNG

    Concentric by Ginkgo Stands Ready to Continue Fighting Pandemic, Providing Biosecurity and COVID Testing Nationwide to Schools, Workplaces, and Other Congregate Settings

    BOSTON, Sept. 10, 2021 /PRNewswire/ -- Ginkgo Bioworks ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced its readiness to continue scaling support for COVID testing in congregate settings in response to new emergency standards and recommendations issued by the Biden-Harris Administration. Ginkgo, which recently announced a business combination with Soaring Eagle Acquisition Corp. (NASDAQ:SRNG), serves customers across industries seeking to develop new and better products using biology. Last year, Ginkgo launched Concentric by Ginkgo, its public health and biosecurity initiative, to provide a response to the COVID-19 pandemic. Since then, Conc

    9/10/21 3:00:00 PM ET
    $SRNG

    $SRNG
    SEC Filings

    View All

    SEC Form EFFECT filed by Soaring Eagle Acquisition Corp.

    EFFECT - Ginkgo Bioworks Holdings, Inc. (0001830214) (Filer)

    9/21/21 12:15:16 AM ET
    $SRNG

    SEC Form 424B3 filed by Soaring Eagle Acquisition Corp.

    424B3 - Ginkgo Bioworks Holdings, Inc. (0001830214) (Filer)

    9/20/21 5:24:23 PM ET
    $SRNG

    Soaring Eagle Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Changes in Registrant’s Certifying Accountant, Material Modification to Rights of Security Holders, Other Events, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Change in Shell Company Status

    8-K - Ginkgo Bioworks Holdings, Inc. (0001830214) (Filer)

    9/20/21 5:19:07 PM ET
    $SRNG

    $SRNG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3: New insider Cascade Investment, L.L.C. claimed ownership of 151,865,481 units of Class A Common Stock

    3 - Ginkgo Bioworks Holdings, Inc. (0001830214) (Issuer)

    9/24/21 4:24:22 PM ET
    $SRNG

    SEC Form 3: New insider Viking Global Investors Lp claimed ownership of 339,055,144 units of Class A Common Stock

    3 - Ginkgo Bioworks Holdings, Inc. (0001830214) (Issuer)

    9/23/21 4:11:12 PM ET
    $SRNG

    SEC Form 4: Eagle Equity Partners Iii, Llc returned 11,534,052 units of Class A Common Stock to the company, decreasing direct ownership by 27% to 31,590,948 units

    4 - Ginkgo Bioworks Holdings, Inc. (0001830214) (Issuer)

    9/22/21 9:57:03 PM ET
    $SRNG

    $SRNG
    Financials

    Live finance-specific insights

    View All

    Ginkgo Bioworks Announces Date of First Half 2021 Results Presentation

    BOSTON, Aug. 9, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo"), which recently announced a business combination with Soaring Eagle Acquisition Corp. (NASDAQ:SRNG), announced that it will host a presentation reviewing results for the first six months of 2021 after the market closes on Wednesday, August 18, 2021, beginning at 4:30 p.m. ET. The presentation will include an overview of first half performance, recent updates, and a discussion on Ginkgo's business model and outlook. The presentation details and registration link will be available on Ginkgo's investor relation

    8/9/21 7:00:00 AM ET
    $SRNG

    $SRNG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Soaring Eagle Acquisition Corp. (Amendment)

    SC 13D/A - Ginkgo Bioworks Holdings, Inc. (0001830214) (Subject)

    10/1/21 5:02:37 PM ET
    $SRNG

    SEC Form SC 13G filed by Soaring Eagle Acquisition Corp.

    SC 13G - Ginkgo Bioworks Holdings, Inc. (0001830214) (Subject)

    9/28/21 4:31:04 PM ET
    $SRNG

    SEC Form SC 13G filed by Soaring Eagle Acquisition Corp.

    SC 13G - Ginkgo Bioworks Holdings, Inc. (0001830214) (Subject)

    9/27/21 5:29:26 PM ET
    $SRNG